Adjust Text Size:
Browse Clinical Trials
Join the Email List
Sign up for our email bulletin
Participant Stories
“I feel like there is hope, great hope, more hope now than ever before.” –Peggy Willocks, Diagnosed 14 years
Recently Diagnosed with Parkinson's Disease?
If you have recently been diagnosed with Parkinson’s disease (PD) understanding the disease, and learning about the resources available to you, are good first steps.
News Archive
Manufacturer of the Parkinson's Patch Announces Recall of US Batches
Mar 22 2008
UCB Inc., the company that manufactures rotigotine (Neupro(R)), the transdermal patch treatment that is used to ease the symptoms of Parkinson’s disease in its early stages, has announced a recall of all Neupro batches in the United States and some areas of Europe. The company has assured the public that the recall has been made not because of concern about contamination or toxicity, but because of a deviation from approved product standards that has apparently reduced the effectiveness of the treatment.
Because correction of the problem and the replenishment of the batches will take time, patients on Neupro are being advised to contact their health care professionals to arrange for their doses to be reduced slowly over time, as advised on the product label. The company advises strongly against sudden discontinuation.
Dr. Christopher Goetz, Director of the Parkinson’s Disease Foundation Research Center at Rush University Medical Center in Chicago, says that for patients now on Neupro, the physician may recommend switching to one of the oral medications known as dopamine agonists that are in the same drug class as Neupro.
Source Publication: Bloomberg
View source URL
